CNBCLean R·
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Read at CNBC →
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
<iframe src="https://statesidedaily.com/embed/cluster/f5cc908b515d42e2d6622ed09483b2be43a2aa5d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo says Wegovy injection lowers BMI and obesity rates in children in trial"></iframe>